Security007903BD8 / Advanced Micro Devices, Inc. Bond 2.125%, 9/1/2026 (007903BD8)
Institutional Owners68
Institutional Shares68,423,155 - 7.06%
Common Shares Outstanding969,110,191 shares (as of 2017-12-30)
Institutional Value$ 1,879,254,000 USD

Institutional Bond Ownership and Shareholders

Advanced Micro Devices, Inc. Bond 2.125%, 9/1/2026 (007903BD8) has 68 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68,423,155 shares. Largest shareholders include Graham Capital Management, L.P., State Street Corp, Bank Of Nova Scotia, Mohican Financial Management, LLC, Bank of New York Mellon Corp, AMP Capital Investors Ltd, Verde Servicos Internacionais S.A., Oppenheimer Asset Management Inc., Front Row Advisors Llc, and North Star Investment Management Corp..

Advanced Micro Devices, Inc. Bond 2.125%, 9/1/2026 (007903BD8) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-09 13F-HR ONTARIO TEACHERS PENSION PLAN BOARD 28,380 21,061 -25.79
2018-02-14 13F-HR Man Investments (CH) AG 436 300 -31.19
2018-02-09 13F-HR PALISADE CAPITAL MANAGEMENT LLC/NJ 6,027 5,106 -15.28
2018-02-14 13F-HR MORGAN STANLEY 225 1,308 481.33
2018-02-09 13F-HR Bank of New York Mellon Corp 750,000 754,000 0.53 1,329 1,137 -14.45
2018-02-14 13F-HR Magnetar Financial LLC 44,745 38,483 -13.99
2018-02-07 13F-HR AGF INVESTMENTS INC. 4,737
2018-02-14 13F-HR SHENKMAN CAPITAL MANAGEMENT INC 4,727 5,647 19.46
2018-04-13 13F-HR Calamos Advisors LLC 44,736 42,992 -3.90
2018-02-02 13F-HR GABELLI FUNDS LLC 3,121 2,653 -15.00
2018-02-14 13F-HR Kohlberg Kravis Roberts & Co. L.P. 38,506 33,351 -13.39
2018-01-31 13F-HR Opera Trading Capital 31,777 27,004 -15.02
2018-02-08 13F-HR Granite Point Capital Management, L.P. 500,000 886 751 -15.24
2018-02-07 13F-HR OPPENHEIMER ASSET MANAGEMENT INC. 27,000 27,000 0.00 48 48 0.00
2018-02-14 13F-HR QVT Financial LP 35,479 30,204 -14.87
2018-02-14 13F-HR STATE STREET CORP 26,575,000 24,625,000 -7.34 47,395 37,398 -21.09
2018-02-09 13F-HR SSI INVESTMENT MANAGEMENT INC 5,268 3,245 -38.40
2017-11-14 13F-HR PUTNAM INVESTMENTS LLC 1,158,000 0 -100.00 2,028 0 -100.00
2017-11-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,134 3,543 -73.02
2018-02-12 13F-HR Hudson Bay Capital Management LP 172,982 142,386 -17.69
2018-02-12 13F-HR CITIGROUP INC 154 18 -88.31
2017-11-14 13F-HR WESTERN ASSET MANAGEMENT CO 14,170 2 -99.99
2018-02-14 13F-HR ROYAL BANK OF CANADA 7 7 0.00
2017-11-13 13F-HR ANGELO GORDON & CO., L.P. 23,162 33,168 43.20
2018-02-01 13F-HR BNP Paribas Investment Partners S.A. 11,430 25,651 124.42
2018-02-14 13F-HR CSS LLC/IL 13,878 8,004 -42.33
2018-01-16 13F-HR/A-1 Mohican Financial Management, LLC 1,900,000 900,000 -52.63 3,357 1,352 -59.73
2017-11-13 13F-HR Nicholas Investment Partners, LP 5,429 2,090 -61.50
2017-11-13 13F-HR FMR LLC / Fidelity 13,152 11,177 -15.02
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 21,498 3,491 -83.76
2018-02-12 13F-HR Brown Advisory Securities, LLC 20 19 -5.00
2018-02-14 13F-HR BRIGADE CAPITAL MANAGEMENT, LP 48,091 12,225 -74.58
2018-04-13 13F-HR North Star Investment Management Corp. 1,000 1,000 0.00 2 1 -50.00
2018-02-13 13F-HR Oz Management LP 102,389 86,102 -15.91
2018-02-13 13F-HR JP Morgan Chase & Co 9,381 6,283 -33.02
2018-02-02 13F-HR GABELLI SECURITIES, INC. 267 227 -14.98
2018-02-14 13F-HR UBS Group AG 5 5 0.00
2017-11-14 13F-HR Hutchin Hill Capital, LP 19,235 20,377 5.94
2018-02-14 13F-HR DEUTSCHE BANK AG\ 8,236 10,661 29.44
2018-02-14 13F-HR CNH PARTNERS LLC 103,498 98,085 -5.23
2018-02-12 13F-HR AMERIPRISE FINANCIAL INC 4,610 3,897 -15.47
2018-02-14 13F-HR WOLVERINE ASSET MANAGEMENT LLC 147,957 125,488 -15.19
2018-02-14 13F-HR STEELHEAD PARTNERS LLC 28,348 24,040 -15.20
2018-02-09 13F-HR BlackRock Inc. 3,927 3,330 -15.20
2018-01-31 13F-HR Front Row Advisors Llc 1,000 2
2018-02-13 13F-HR Allianz Asset Management AG 73,993 70,644 -4.53
2018-04-13 13F-HR Verde Servicos Internacionais S.A. 0 30,000 0 4,403
2018-02-13 13F-HR ADVENT CAPITAL MANAGEMENT /DE/ 14,226 12,420 -12.70
2018-02-14 13F-HR Advisor Group, Inc. 12 7 -41.67
2018-02-14 13F-HR AMP Capital Investors Ltd 0 175,000 0 265
2017-10-16 13F-HR BANK OF MONTREAL /CAN/ 4
2018-01-19 13F-HR Steward Partners Investment Advisory, Llc 1 1 0.00
2018-02-14 13F-HR Natixis Asset Management 155 155 0.00 277 236 -14.80
2018-02-14 13F-HR BARCLAYS PLC 2,255 54 -97.61
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 13,885 3,447 -75.17
2018-02-13 13F-HR BANK OF NOVA SCOTIA 1,910,000 1,910,000 0.00 3,387 2,868 -15.32
2018-02-14 13F-HR Invesco Ltd. 12,399 7,509 -39.44
2018-02-14 13F-HR Linden Advisors LP 119,717 115,782 -3.29
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 432 8,699 1,913.66
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 531 451 -15.07
2018-02-14 13F-HR Graham Capital Management, L.P. 40,000,000 40,000,000 0.00 70,876 60,138 -15.15
2018-01-24 13F-HR MACKAY SHIELDS LLC 28,545 24,068 -15.68
2018-02-14 13F-HR Polar Asset Management Partners Inc. 8,860 7,512 -15.21
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 708,500 600,752 -15.21
2018-02-13 13F-HR LAZARD ASSET MANAGEMENT LLC 8,868 3,673 -58.58
2018-02-14 13F-HR LORD, ABBETT & CO. LLC 10,478 6,293 -39.94
2018-02-09 13F-HR CAMDEN ASSET MANAGEMENT L P /CA 48,683 42,781 -12.12
2018-04-13 13F-HR CALAMOS WEALTH MANAGEMENT LLC 103 103 0.00
2018-02-14 13F-HR Mint Tower Capital Management B.V. 35,512 30,088 -15.27

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 007903BD8